| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2024 ASH Annual Meeting
|
Marín, Daniela
|
|
|
12 |
2 |
p. e91-e92
|
artikel
|
| 2 |
Cristóbal Frutos: confronting treatment barriers
|
Cavanaugh, Ray
|
|
|
12 |
2 |
p. e93
|
artikel
|
| 3 |
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet
|
Ribrag, Vincent
|
|
|
12 |
2 |
p. e138-e150
|
artikel
|
| 4 |
Expanding treatment options for warm autoimmune haemolytic anaemia
|
Berentsen, Sigbjørn
|
|
|
12 |
2 |
p. e84-e85
|
artikel
|
| 5 |
Improved survival and enhanced quality of life through anaemia correction in lower risk myelodysplastic syndromes: meaningful insights from an EUMDS Registry study
|
Niscola, Pasquale
|
|
|
12 |
2 |
p. e88-e90
|
artikel
|
| 6 |
Inclusion matters: progress in haematological trials for pregnant individuals
|
The Lancet Haematology,
|
|
|
12 |
2 |
p. e83
|
artikel
|
| 7 |
Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial
|
Bugge Askeland, Frida
|
|
|
12 |
2 |
p. e120-e127
|
artikel
|
| 8 |
Is it time for a large trial to evaluate aspirin for obstetric venous thromboembolism prophylaxis?
|
Friedman, Alexander M
|
|
|
12 |
2 |
p. e85-e86
|
artikel
|
| 9 |
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial
|
Skeith, Leslie
|
|
|
12 |
2 |
p. e109-e119
|
artikel
|
| 10 |
Optimising quadruplet regimens to broaden eligibility in multiple myeloma
|
Wildes, Tanya M
|
|
|
12 |
2 |
p. e87-e88
|
artikel
|
| 11 |
Pioneering a new field of computational pharmacophenomics to unlock the life-saving potential of existing medicines
|
Fajgenbaum, David C
|
|
|
12 |
2 |
p. e94-e96
|
artikel
|
| 12 |
Position statement on the diagnosis and management of acute leukaemia and aggressive lymphomas in pregnancy
|
Mills, Georgia
|
|
|
12 |
2 |
p. e151-e162
|
artikel
|
| 13 |
Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study
|
Zhao, Xin
|
|
|
12 |
2 |
p. e97-e108
|
artikel
|
| 14 |
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study
|
Gravdahl Garelius, Hege Kristin
|
|
|
12 |
2 |
p. e128-e137
|
artikel
|
Tijdschrift beschrijving